Renaud S, De Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease [J]. Lancet, 1992, 339(8808):1523.
[2]
Atten M J, Godoy-Romero E, Attar B M. Resveratrol regulates cellular PKC α and δ to inhibit growth and induce apoptosis in gastric cancer cells [J]. Invest New Drugs,2005, 23(2):111.
Mackenzie P I, Bock K W, Burchell B, et al. Nomenclature update for the mammalian UDP-glycosyltransferase (UGT) gene superfamily[J]. Pharmacogenet Genomics, 2005,15(10): 677.
[8]
Iwuchukwu O F,S Nagar. Resveratrol (trans-resveratrol, 3, 5, 4\'-trihydroxy-trans-stilbene) glucuronidation exhibits atypical enzyme kinetics in various protein sources[J]. Drug Metab Dispos, 2008, 36(2): 322.
Guengerich F P. Analysis and characterization of enzymes in principles and methods of toxicology[M]. New York :Raven Press, 1989:777.
[11]
Zhang J W. Metabolic profiling and cytochrome P450 reaction phenotyping of medroxyprogesterone acetate[J]. Drug Metab Dispos, 2008, 36:2292.
[12]
Iwuchukwu O F, S Nagar. Characterizing the effects of common UDP glucuronosyltransferase(UGT)1A6 and UGT1A1 polymorphisms on cis- and trans-resveratrol glucuronidation [J]. Drug Metab Dispos, 2009, 37 (8): 1726.
[13]
Liang S C, Ge G B, Yang L. Identification and characterization of human UDP-glucuronosyltransferases responsible for the in vitro glucuronidation of daphnetin [J]. Drug Metab Dispos, 2010, 38(6): 973.
Brill S S, Furimsky A M, Ho M N, et al. Glucuronidation of trans-resveratrol by human liver and intestinal microsomes and UGT isoforms[J]. J Pharm Pharmacol, 2006, 58(4):469.
[18]
Vitaglione P, Sforza S, Galaverna G, et al. Bioavailability of trans-resveratrol from red wine in humans[J]. Mol Nutr Food Res, 2005, 49(5):495.
[19]
Maier-Salamon Alexandra, Bohmdorfer Michaela, Thalhammer Theresia,et al. Hepatic glucuronidation of resveratrol: interspecies comparison of enzyme kinetic profiles in human, mouse, rat, and dog[J]. Drug Metab Pharmacokinetics, 2011, 26(4): 364.
[20]
Sabolovic N, Humbert A C, Radominska-Pandya A, et al. Resveratrolis is efficiently glucuronidated by UDP-glucuronosyltransferases in the human gastrointestinal tract and in Caco-2 cells[J]. Biopharm Drug Dispos,2006,27(4):181.
[21]
Iwuchukwu Otito F,Tallarida Ronald J, Nagar Swati. Resveratrol in combination with other dietary polyphenols concomitantly enhances antiproliferation and UGT1A1 induction in Caco-2 cells[J]. Life Sciences, 2011, 88(23/24): 1047.
[22]
Nagar S and Remmel R P. Uridine diphosphoglucuronosyltransferase pharmacogenetics and cancer[J]. Oncogene, 2006, 25:1659.
[23]
Iwuchukwu O F, S Nagar. Cis-resveratrol glucuronidation kinetics in human and recombinant UGT1A sources[J]. Xenobiotica, 2010, 40(2): 102.
